John Libbey Eurotext

European Journal of Dermatology


Psoriatic arthritis flare-up after a second dose of BNT162b2 COVID-19 mRNA vaccine Volume 32, numéro 3, May-June 2022


  • Figure 1.
Department of Dermatology, Iwate Medical University School of Medicine, 2-1-1, Idaidori, Yahabacho, Iwate 028-3695, Japan

Recently, due to the COVID-19 pandemic, SARS-CoV-2 vaccination has been underway worldwide. The most common cutaneous reactions to COVID-19 mRNA vaccination are local injection site reactions, urticaria, and morbilliform rash [1]. Here, we report a case of exacerbation of psoriatic arthritis (PsA) in a patient after receiving the BNT162b2 COVID-19 mRNA vaccine.The patient was a 38-year-old woman with a three-year history of PsA. Her skin and joint symptoms had been well controlled for 11 months [...]